Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [906]

METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer

Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA

METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer ( Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA )

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as...

Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta...

CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC ( Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, USA )

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Prof Benjamin Besse and Dr Alex Spira

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer ( Prof Benjamin Besse and Dr Alex Spira )

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy...

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA

KEYNOTE-604: Pembrolizumab plus etoposide and platinum as a first-line therapy for extensive-stage small-cell lung cancer ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York City, USA )

Brigatinib for NSCLC, latest research and overcoming complications

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Brigatinib for NSCLC, latest research and overcoming complications ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

Sym015 shows superior specificity compared to TKIs for NSCLC

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA

Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

Prof Roy Herbst - Yale Cancer Center, New Haven, USA

ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Dr Edward Garon - UCLA Medical Center, Santa Monica, USA

Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )

COVID-19: Risk of millions relapsing back to smoking

Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton...

COVID-19: Risk of millions relapsing back to smoking ( Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton, UK )

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in...

Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19 ( Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA )

COVID-19: Management of non-small cell lung cancer patients during the...

Dr Heather Wakelee - Stanford University, Stanford, USA

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )

Prostate cancer patients receiving androgen-deprivation therapies shown to be...

Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona...

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )

More from ecancer